← All recalls

Recall · CPSC (US)

Mohnark Pharmaceuticals Recalls Lidocaine Topical Anesthetic Cream Due to Failure to Meet Child-Resistant Packaging Requirement; Risk of Poisoning (Recall Alert)

Mohnark Pharmaceuticals Inc., of Davie, Fla.·Other·

Yes. Mohnark Pharmaceuticals Inc., of Davie, Fla.'s product was recalled on June 30, 2022 by CPSC (US). Reported hazard: The product contains lidocaine which must be in child resistant packaging as required by the Poison Prevention Packaging Act (PPPA). The packaging is not child resistant, posing a risk of poisoning to young children if they ingest the anesthetic cream. What to do: Consumers should immediately stop using the recalled cream and store it in a location out of sight and reach of children. Contact Mohnark Pharmaceuticals for instructions on how to dispose of the product to receive a full refund. Mohnark Pharmaceuticals is contacting all known purchasers directly.

Data updated September 22, 2026 · Source: official CPSC (US) recall data, checked daily

Mohnark Pharmaceuticals Recalls Lidocaine Topical Anesthetic Cream Due to Failure to Meet Child-Resistant Packaging Requirement; Risk of Poisoning (Recall Alert)

What was recalled

The recall involves Mohnark Pharmaceuticals Lidocaine 4% Topical Anesthetic Cream. The product was sold in a white tube with a flip-top closure. Mohnark Pharmaceuticals is printed under the blue and green logo on the right side of the product tube. The lot code is located at the bottom of the product tube. The affected lot codes are 01202201, 210201, 210301, 210503, 210505, 210601, 211002 and 210401. The UPC 860002324906 is located on bottom side panel of the packaging.

The hazard

CPSC (US) flagged this Mohnark Pharmaceuticals Inc., of Davie, Fla. product for the following risk:

The product contains lidocaine which must be in child resistant packaging as required by the Poison Prevention Packaging Act (PPPA). The packaging is not child resistant, posing a risk of poisoning to young children if they ingest the anesthetic cream.

What to do

If you own a Mohnark Pharmaceuticals Inc., of Davie, Fla. product, here is the remedy CPSC (US) lists:

Consumers should immediately stop using the recalled cream and store it in a location out of sight and reach of children. Contact Mohnark Pharmaceuticals for instructions on how to dispose of the product to receive a full refund. Mohnark Pharmaceuticals is contacting all known purchasers directly.

Original recall notice: CPSC (US) →

Common questions

Is the Mohnark Pharmaceuticals Inc., of Davie, Fla. product recalled?

Yes. Mohnark Pharmaceuticals Inc., of Davie, Fla.'s product was recalled on June 30, 2022 by CPSC (US). Reported hazard: The product contains lidocaine which must be in child resistant packaging as required by the Poison Prevention Packaging Act (PPPA). The packaging is not child resistant, posing a risk of poisoning to young children if they ingest the anesthetic cream.

What should I do if I have this product?

Consumers should immediately stop using the recalled cream and store it in a location out of sight and reach of children. Contact Mohnark Pharmaceuticals for instructions on how to dispose of the product to receive a full refund. Mohnark Pharmaceuticals is contacting all known purchasers directly.

Where can I read the official recall notice?

The original notice is published by CPSC (US) — linked directly from this page.

Want to hear about recalls like this without checking?

We monitor CPSC, FDA, and EU Safety Gate daily. Recall info is always free.

One email a week. Unsubscribe anytime.

Other recalls

More other recalls Pouch has tracked. See all →